Akron Children's > For Families & Patients > Research > Pediatric Clinical Studies > Open Clinical Studies

Biomarkers in Newborns With Down Syndrome

Study of Biomarkers found in Newborns with Down Syndrome and the Link to Leukemia

Description:

For complete study information, please view the study on clinicaltrials.gov.

Study Status:

Closed

Full IRB Study Title:

AAML08B: Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)

IRB Study ID:

101003

If you are interested in this study or have questions about your child's eligibility, please contact:

Rebecca D. Considine Research Institute, 330-543-3193 or email research@akronchildrens.org

While we are ranked among the best children's hospitals in the country, it's our compassionate approach to treatment that makes us truly exceptional. Through a combination of revolutionary treatments and extraordinary patient experiences, our care does more than heal. It brings the entire family together for emotional support and understanding across multiple locations to reach you in the community where you live. Learn more...